Sign in

CIK 0000072444

  • Accelerated filer
  • Smaller reporting company

Vaxart, Inc.

Sign in to watch
Ticker
VXRT
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
591212264
Phone
+1 650-550-3500
Business address
310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
Former names
Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2008-03-05 Kessler Paul D. SVP Clinical, Med. & Reg.; CMO Sale −754 $3.74 $3K 41,840
2008-03-05 Kessler Paul D. SVP Clinical, Med. & Reg.; CMO Sale −600 $3.74 $2K 41,240
2008-03-05 FAHIM RAAFAT E F President and CEO Sale −2,100 $3.75 $8K 127,567.27
2008-03-05 FAHIM RAAFAT E F President and CEO Sale −1,825 $3.75 $7K 125,742.27
2008-03-05 FAHIM RAAFAT E F President and CEO Sale −2,725 $3.76 $10K 123,017.27
2008-03-05 FAHIM RAAFAT E F President and CEO Sale −250 $3.77 $943 122,767.27
2008-03-05 FAHIM RAAFAT E F President and CEO Sale −200 $3.77 $754 122,567.27
2008-03-05 FAHIM RAAFAT E F President and CEO Sale −400 $3.78 $2K 122,167.27
2008-03-05 Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas Sale −2,100 $3.80 $8K 91,057.19
2008-03-05 Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas Sale −3,200 $3.80 $12K 87,857.19
2008-03-05 Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas Sale −300 $3.78 $1K 87,557.19
2008-03-05 Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas Sale −1,900 $3.80 $7K 85,657.19
2008-01-22 FAHIM RAAFAT E F President and CEO Grant or award +50,000 176,730.42
2008-01-22 FAHIM RAAFAT E F President and CEO Grant or award +7,000 183,730.42
2007-10-15 Hudson Leslie Interim President & CEO Grant or award +20,000 31,759
2007-10-15 Hudson Leslie Interim President & CEO Grant or award +48,000 79,759
2007-08-15 Hudson Leslie Interim President & CEO Returned to the company −1,307 11,759
2007-05-18 SUDOVAR STEPHEN Director Grant or award · Stock Option (right to buy) +20,000 20,000
2007-05-18 Siegel Jordan I Sr. VP, Fin., CFO and Treas. Grant or award +30,000 90,000
2007-05-18 Siegel Jordan I Sr. VP, Fin., CFO and Treas. Grant or award · Stock Option (right to buy) +90,000 90,000

Page 38 of 42 · 830 trades